We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+1.78%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.34B
AUM Growth
–
Cap. Flow
+$5.62B
Cap. Flow
% of AUM
105.35%
Top 10 Holdings %
Top 10 Hldgs %
16.76%
Holding
517
New
456
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$173M |
| 2 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$92.2M |
| 3 |
Mondelez International
MDLZ
|
+$78.2M |
| 4 |
Estee Lauder
EL
|
+$66.3M |
| 5 |
Coca-Cola
KO
|
+$65.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 14.12% |
| 2 | Real Estate | 12.96% |
| 3 | Consumer Discretionary | 7.68% |
| 4 | Healthcare | 7.54% |
| 5 | Financials | 5.81% |
Similar funds
FNBT
SAG
ACI
TCOV
RC
A
CGL
CB
UBS O'Connor's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for UBS O'Connor, which disclosed 517 positions worth $5.34B. Its ten largest holdings account for 17% of the portfolio.
Its largest position is Pfizer: 6,269,077 shares worth $167M.
By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, followed by Real Estate and Consumer Discretionary.
- UBS O'Connor's largest Q2 2013 buy was Pfizer: 6,269,077 shares worth $167M.
- UBS O'Connor's ten largest holdings make up 17% of its $5.34B portfolio in Q2 2013.
- UBS O'Connor disclosed 517 positions in Q2 2013, its first 13F filing on record.
Based on UBS O'Connor's 13F filing for Q2 2013, filed 13 Aug 2013.